Global Sources
EE Times-Asia
Stay in touch with EE Times Asia
EE Times-Asia > Sensors/MEMS

Duo develops nano biosensors for elderly care

Posted: 24 Jun 2010 ?? ?Print Version ?Bookmark and Share

Keywords:nano biosensor? healthcare? nanotechnology?

ActiveCare Inc. and Vista Therapeutics Inc. have forged a strategic relationship to develop nano biosensors for ActiveCare's products and services for the elderly.

The terms of the strategic agreement call for ActiveCare to make an equity investment in Vista and to pay a fee for the development of products utilizing its Nano Biosensor Technology. In addition, Vista CEO and chairman, Dr. Spencer Farr, has agreed to serve on ActiveCare's advisory board to help identify new products and services for ActiveCare.

The biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, president of ActiveCare. "Through the use of Vista's nanotechnology, which allows extreme miniaturization combined with continuous monitoring, we will be able to monitor continuously at our CareCenter specific drug and disease indicators, allowing us to react quickly to a pending acute event. It is ActiveCare's goal to combine Vista's biosensors into the company's ActiveOne+ watch which is worn by the senior and transmits back to ActiveCare's 24/7 CareCenter. This technology could truly revolutionize how we care for our senior population."

Vista specializes in developing nanotechnology. Through exclusive license agreements with Nanosys Inc. and Harvard University, Vista is developing and marketing nanowire-based biosensors that detect and can take measurements of over 250 indicators or markers. The strategic agreement between Vista and ActiveCare is to integrate Vista's technology into ActiveCare's products ultimately providing real-time accurate medical information.

As part of the strategic agreement, ActiveCare will have exclusive use of the Vista's technology in the elderly market (excluding hospitals, for which ActiveCare will also have the right to acquire an exclusive sub-license).

Article Comments - Duo develops nano biosensors for eld...
*? You can enter [0] more charecters.
*Verify code:


Visit Asia Webinars to learn about the latest in technology and get practical design tips.

Back to Top